n India, so far somaclonal variation is the only biotechnological approach to give a commercial variety. A somaclonal variant of Citronella java, a medicinal plant, has been released as 'Bio-l3' for commercial cultivation by CIMAP (Central Institute for Medicinal and Aromatic Plants), Lucknow. Bio- 13 yields 37% more oil and 39% more citronellol than the control varieties.
A somaclonal variant of the B. juncea variety 'Varuna' has been released for commercial cultivation as 'Pusa Jai Kisan'. The new variety has bolder seeds and some yield advantage over the parent variety Varuna. A somaclone of khesari (Lathyrus sativus) has low neutrotoxin (BoAA) content; it has been released as 'Ratan' for commercial cultivation.
|